您的位置: 首页 > 农业专利 > 详情页

PHARMACEUTICAL COMBINATION FOR TREATMENT OF FABRY DISEASE AND USE THEREOF
专利权人:
MEIJI PHARMACEUTICAL UNIVERSITY
发明人:
Takahiro TSUKIMURA,Tadayasu TOGAWA,Hitoshi SAKURABA
申请号:
US16622706
公开号:
US20200115698A1
申请日:
2018.06.14
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present invention provides a pharmaceutical combination for treatment of Fabry disease and use thereof. The present invention relates to a pharmaceutical combination for treating Fabry disease, and the pharmaceutical combination includes (i) a protein which has mutations in an amino acid sequence of α-N-acetylgalactosaminidase and has α-galactosidase activity and (ii) an active site specific chaperone.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充